Li et al. first investigated the fasting plasma levels of nesfatin-1 in type 2 diabetes patients and found that fasting nesfatin-1 levels were significantly lower in the type 2 diabetes group compared with the levels in healthy subjects [12]. Here, NUCB2 is linked to type 2 diabetes mellitus.